Learn how Louisiana medical marijuana doctors and patients can prepare for federal marijuana rescheduling and what patients should do to stay informed about changing recommendations, documentation, and dispensary requirements.

As of early July 2026, state-licensed medical marijuana and FDA-approved marijuana products have been moved from Schedule I to Schedule III federally under a DOJ/DEA order that took effect April 28, 2026. This is a major change, but it does not legalize marijuana nationwide, allow recreational sales federally, or automatically solve banking, interstate-commerce, workplace, or […]

The federal government is taking one of its biggest steps yet toward recognizing medical marijuana businesses under federal law. In recent weeks, the Drug Enforcement Administration (DEA) launched new registration forms and an online application portal for state-licensed medical marijuana dispensaries and related cannabis businesses. The move follows a major policy shift by the U.S. […]

The U.S. government has made one of the most significant changes to marijuana policy in decades. In April 2026, the Drug Enforcement Administration (DEA), under direction from the U.S. Department of Justice, officially moved certain medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act. For patients who rely on medical cannabis, this […]

Rescheduling marijuana. Will it be good or bad for medical marijuana? This article explores the benefits and the pitfalls should the DEA accept the recommendation from President Donald Trump to reschedule marijuana.

Marijuana is on track to be rescheduled from Schedule 1 to Schedule III on the Drug Enforcement Agency’s (DEA) controlled substances list. But what will that mean for medical marijuana patients in Louisiana? In this article, we’ll define the list and how rescheduling might affect marijuana patients and businesses in Louisiana. The History of Marijuana […]